These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12057547)

  • 21. A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.
    Zanotti-Fregonara P; Grassetto G; Hindié E; Rubello D
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):169-71. PubMed ID: 18850097
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A thyroid nodule overtreated twice.
    Yu R
    Endocrinol Diabetes Nutr; 2017; 64(7):396-397. PubMed ID: 28968220
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.
    Pacini F; Castagna MG
    Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):1009-21. PubMed ID: 19041828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of differentiated thyroid carcinoma.
    Cox AE; LeBeau SO
    Radiol Clin North Am; 2011 May; 49(3):453-62, vi. PubMed ID: 21569904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries. What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
    Albrecht AM; Paulson CP; Kovach FE
    J Fam Pract; 2009 Dec; 58(12):E4. PubMed ID: 19961815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of Care.
    Levy EG
    Thyroid; 2000 Dec; 10(12):1119-21. PubMed ID: 11201859
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of measurement of serum thyroglobulin in patients with differentiated thyroid carcinoma after total thyroidectomy--a marker of metastases].
    Kusakabe K; Ohta Y; Kawasaki Y; Maki M; Hiroe M; Shigeta T; Obara T; Fujimoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 May; 47(5):745-53. PubMed ID: 3658661
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of recombinant thyroid-stimulating hormone (rhTSH) in the detection and management of well-differentiated thyroid carcinoma: a roundtable discussion.
    Schlumberger MJ; Incerti C; Pacini F; Reiners C
    J Endocrinol Invest; 1999; 22(11 Suppl):35-41. PubMed ID: 10727004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels.
    Schlumberger M; Charbord P; Fragu P; Lumbroso J; Parmentier C; Tubiana M
    J Clin Endocrinol Metab; 1980 Sep; 51(3):513-9. PubMed ID: 7410531
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.
    Wang TS; Evans DB; Fareau GG; Carroll T; Yen TW
    Ann Surg Oncol; 2012 Dec; 19(13):4217-22. PubMed ID: 23010732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of simultaneous measurement of serum thyroglobulin and thyroglobulin antibody during the follow-up of patients with differentiated thyroid carcinoma].
    Lõcsei Z; Horváth D; Rácz K; Toldy E
    Orv Hetil; 2011 May; 152(19):743-52. PubMed ID: 21498164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing.
    Greenspan FS
    Thyroid; 1996 Oct; 6(5):493. PubMed ID: 8936677
    [No Abstract]   [Full Text] [Related]  

  • 35. Thyroid carcinoma.
    Tuttle RM; Ball DW; Byrd D; Dilawari RA; Doherty GM; Duh QY; Ehya H; Farrar WB; Haddad RI; Kandeel F; Kloos RT; Kopp P; Lamonica DM; Loree TR; Lydiatt WM; McCaffrey JC; Olson JA; Parks L; Ridge JA; Shah JP; Sherman SI; Sturgeon C; Waguespack SG; Wang TN; Wirth LJ;
    J Natl Compr Canc Netw; 2010 Nov; 8(11):1228-74. PubMed ID: 21081783
    [No Abstract]   [Full Text] [Related]  

  • 36. Do all cancers need to be treated? The role of thyroglobulin in the management of thyroid cancer: the 2006 Hayes Martin lecture.
    Heller KS
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):639-43. PubMed ID: 17638774
    [No Abstract]   [Full Text] [Related]  

  • 37. Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation.
    Weiss R; Magner J
    Thyroid; 2015 Jun; 25(6):708-10. PubMed ID: 25850337
    [No Abstract]   [Full Text] [Related]  

  • 38. [Annex II: thyroglobulin determination in the follow up of differentiated cancers of the thyroid vesicular structure].
    Ann Endocrinol (Paris); 2007 Dec; 68 Suppl 2():S77-80. PubMed ID: 18342283
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent thyroid cancer.
    Clark OH
    J Endocrinol Invest; 1995 Feb; 18(2):167-9. PubMed ID: 7629391
    [No Abstract]   [Full Text] [Related]  

  • 40. Epithelial cell thyroid cancer and thyroid stimulating hormone--when less is more.
    Emerson CH; Colzani R; Braverman LE
    J Clin Endocrinol Metab; 1997 Jan; 82(1):9-10. PubMed ID: 8989222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.